Betta Pharmaceuticals Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Net Income	441.16	305.33	402.57	348.03	145.42	383.07
Depreciation & Amortization	550.76	550.76	371.97	303.49	253.7	174.46
Loss (Gain) From Sale of Assets	-0.38	-0.38	0.59	0.01	-88.61	-0.07
Asset Writedown & Restructuring Costs	0.01	0.01	28.05	1.07	3.01	0.03
Loss (Gain) From Sale of Investments	79.33	79.33	40.97	13.67	20.62	-15.96
Provision & Write-off of Bad Debts	-0.2	-0.2	-6.29	5.43	1.44	-
Other Operating Activities	-100.97	68.79	28.44	37.19	166.66	16.53
Change in Accounts Receivable	-290.9	-290.9	156.53	174.2	-198.29	-181.6
Change in Inventory	-91.59	-91.59	37.42	44.67	-78.85	-104.73
Change in Accounts Payable	256.98	256.98	-95.11	14.71	-9.1	205.07
Change in Other Net Operating Assets	49.42	49.42	-57.13	-16.46	132.53	75.97
Operating Cash Flow	877.33	911.26	911.17	914.23	306.74	526.63
Operating Cash Flow Growth	-8.75%	0.01%	-0.33%	198.05%	-41.75%	-18.48%
Capital Expenditures	-775.77	-616.68	-827.59	-1,096	-1,011	-758.38
Sale of Property, Plant & Equipment	-0.01	0.08	0.14	22.21	0.69	0.24
Cash Acquisitions	-	-	-	-	-	-190.36
Investment in Securities	-311.23	-311.26	-174.24	-431.65	-314.49	-33.62
Investing Cash Flow	-1,087	-927.87	-1,002	-1,505	-1,324	-982.13
Long-Term Debt Issued	-	917.78	644.75	1,890	1,036	-
Long-Term Debt Repaid	-	-820.87	-663.76	-515.82	-8.77	-6.88
Net Debt Issued (Repaid)	206.96	96.91	-19.01	1,374	1,027	-6.88
Issuance of Common Stock	92.17	92.17	-	60.79	53.78	76.7
Common Dividends Paid	-147.33	-150.76	-150.87	-110.28	-139.52	-137.64
Other Financing Activities	-69.97	-64.5	-21.5	-716.49	-	-27.73
Financing Cash Flow	81.83	-26.18	-191.38	608.19	941.52	-95.56
Foreign Exchange Rate Adjustments	0.71	1.08	1.59	3.74	15.38	-2.9
Net Cash Flow	-127.13	-41.7	-280.31	20.71	-60.7	-553.96
Free Cash Flow	101.57	294.58	83.58	-181.79	-703.8	-231.75
Free Cash Flow Growth	-60.14%	252.46%	-	-	-	-
Free Cash Flow Margin	2.72%	8.16%	2.89%	-7.40%	-29.61%	-10.32%
Free Cash Flow Per Share	0.24	0.70	0.20	-0.43	-1.69	-0.56
Cash Income Tax Paid	310.14	262.97	116.65	94.58	111.5	152.36
Levered Free Cash Flow	-310.85	-223.17	-217.99	-963.4	-121.69	-202.98
Unlevered Free Cash Flow	-265.56	-175.58	-189.56	-929.06	0.69	-193.12
Change in Working Capital	-92.37	-92.37	44.88	205.34	-195.49	-31.44

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.